Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Profound Medical Corp well positioned for growth

Tuesday, March 7, 2017 8:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Prostate cancer focused device maker Profound Medical Corp (CVE:PRN) said it was well positioned for growth in 2017 as it posted full year numbers.

The firm was established in 2008 and is developing its TULSA-PRO system, which combines magnetic resonance imaging with therapeutic ultrasound to provide precise ablation of the  prostate organ.

In February last year, it announced a strategic collaboration agreement with Siemens Healthcare to help advance the commercial launch of the system, while in April last year, it received a CE Mark approval for commercial sale.

“2016 was an historic year for Profound in its journey to establish TULSA-PRO system as a new therapeutic standard in prostate cancer,” said Dr Arun Menawat, the chief executive.

“With the invaluable support of our commercial partners, the financial resources required to complete the TACT Pivotal Clinical Trial, and the early success of our pilot commercial launch in Europe, Profound is very well-positioned to continue its strong growth trajectory in 2017.

“We look forward to updating our stakeholders on Profound’s progress in the months ahead.”

The net loss for the year to end December was around $16.32mln, against a net loss of $16.37 mln in the previous year.

Expenditures for R&D (research and development) for the year  were higher by around  $4.85 mln compared to 2015.

The increase was mainly related to the preparation of clinical data from the 30 patient TULSA safety and feasibility trial and due to preparations for an Investigational Device Exemption from the US FDA.

In November, the group announced that it had completed a bought deal offering of 15.82mln sahres at $1.10 per share for gross proceeds of around $17.4 million.

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/174404/profound-medical-corp-well-positioned-for-growth-174404.html

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.